Coronavirus Live Count Map India
remove_red_eye 347 Views
COVID-19 Vaccine Updates
Differences in sugar levels drive breast cancer invasion: IISc study
BENGALURU: A recent study by researchers at Indian Institute of Science shows that a specific sugar called 2,6-linked sialic acid (2,6-Sial) is expressed at different levels on the surface of different breast cancer cells. “Malignant tumors are increasingly being understood and interpreted as ecosystems of heterogeneous cellular entities — a patchwork of cells that look and behave differently, and cooperate or compete with each other as the cancer spreads. Understanding the causes and consequences of such heterogeneity is a clear and present challenge for researchers,” an IISc statement read. .... read more
Ensuring Essential Healthcare Services in the Times of COVID-19
The COVID-19 pandemic caused substantial disruptions in essential health services in most countries. Join us today on MEDtalks with Dr K K Aggarwal COVID edition, at 7:00 PM to understand how we can ensure essential healthcare services during the times of COVID-19.Just click on www.facebook.com/drkkaggarwal or https://perfecthealthmela.com/vevent2/hall1a.php
CMAAO Coronavirus Facts and Myth Buster: Vaccine Reactogenicity (Part 1)
With input from Dr Monica VasudevVaccine Reactogenicity (Part 1)This refers to the physical manifestation of the inflammatory response to vaccination. It may include pain at the injection site, redness, swelling or induration at the injection site, and systemic symptoms, such as fever, myalgia, or headache. Immunogenicity refers to the potential to induce a humoral and/or cell mediated immune response. Reactogenicity is the property of a vaccine to produce excessive immunological responses as well as associated signs and symptoms. .... read more
CMAAO Coronavirus Facts and Myth Buster: Vaccine Reactogenicity (Part 2)
With input from Dr Monica Vasudev Vaccine Reactogenicity (Part 2)Can prophylactic medicines prevent symptoms? 1.A meta-analysis revealed that prophylactic antipyretic drugs led to a significant reduction in injection-site and systemic symptoms following vaccination. However, the use of these drugs was associated with reduced antibody responses to most vaccine antigens. 2.A review suggested that the timing of antipyretic administration was vital, as there was no effect on the antibody response if the antipyretics were given as a treatment for symptoms after vaccination, rather than for the prevention of symptoms. .... read more
Do we get a human birth each time we die?
According to Vedic sciences, Hindu philosophy believes in rebirth unless an individual’s Sanchit and Prarabdha Karmas are completely exhausted. It also believes in liberation wherein once the past karmas debt is over, the person does not take rebirth. Garuda Purana; however, mentions that one can take rebirth in animal species.This means that one can be born as a donkey or a dog or anything else. Vedic science, on the other hand, says that once you get a human body, you will either be liberated or only get another human body. .... read more
Healthcare News Monitor
New Delhi: The makers of two ayurvedic Covid-19 remedies have claimed that the treatments have been found to work better than the standard medicines in a comparative trial. "A clinical trial was conducted in India to monitor the outcome of a combination treatment for Covid. An Ayurvedic Remedy called Immunofree by Corival Life Sciences, and a Nutraceutical called Reginmune by Biogetica is found to work better in a comparative clinical trial against Standard of Care," said a statement.
Artificial intelligence (AI) will transform the pharma industry in the coming years by delivering productivity improvements and efficiencies across the entire pharma value chain, says GlobalData. GlobalData’s latest report, ‘The State of the Biopharmaceutical Industry 2021’, reveals that AI is expected to be the emerging technology that will have the greatest impact on the pharmaceutical industry in 2021, as indicated by *36 per cent of 198 surveyed pharmaceutical industry professionals.
New Delhi: India took only 6 days to administer one million Covid-19 vaccine doses as the number of beneficiaries who have received the anti-coronavirus shots inched close to 16 lakh. This count is higher than that of countries like the US and the UK, the Union Health Ministry said. The UK took 18 days whereas the US took 10 days to reach the one million mark, the ministry said. As on 24 January, till 8 am, nearly 16 lakh (15,82,201) beneficiaries have received COVID-19 vaccination. In a span of 24 hours, close to 2 lakh (1,91,609) people were vaccinated across 3,512 sessions. A total of 27,920 sessions have been conducted so far, the ministry said.
New Zealand has reported its first case of community transmission in more than two months, although there was no immediate evidence that the coronavirus was spreading. Director-General of Health Ashley Bloomfield said Sunday the case was a 56-year-old woman who recently returned from Europe.